Last reviewed · How we verify
NCT03532633
Supply With Micronutrients (Purine and Pyrimidine) in Infants: a Prospective and Observational Study
trial testing cord blood in Prematurity in 150 participants. Status unknown.
1 October 2021
Quick facts
| Lead sponsor | University Hospital Tuebingen |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 March 2017 |
| Primary completion | 1 October 2021 |
| Estimated completion | 1 October 2021 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- cord blood — full drug profile →
- blood sample infant
- blood sample mother
- breast milk — full drug profile →
Conditions studied
- Prematurity — all drugs for Prematurity →
Sponsor
University Hospital Tuebingen
Who can join
Adults 0 Minutes to 6 Months, any sex, with Prematurity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Concentrations of micronutrients (especially purine and pyrimidine) in cord blood, blood of mothers and infants and human milk is studied
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03532633
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prematurity
Currently open trials in the same condition.
- NCT06965530 — Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy · NA · recruiting
- NCT06420531 — Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial · NA · recruiting
- NCT07183462 — Azithromycin and Ampicillin for Late PPROM · Phase 4 · recruiting
- NCT06536296 — The Impact of Music Medicine on Preterm Brain Development and Behavior · NA · recruiting
- NCT07213414 — Metagenomic & Metabolomic Study: Bifidobacterium Probiotic Effects on Gut Microbiota & SCFA in Preterm NICU Infants · EARLY_PHASE1 · active not recruiting
Other University Hospital Tuebingen trials
Trials by the same sponsor.
- NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
- NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
- NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03532633 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
- Last refreshed: 18 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03532633.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing